TCTR20210627002
Recruiting
Not Applicable
Efficacy of the Hemoperfusion Therapy in Patients with Severe COVID-19-Associated Pneumonia: An Experience from Single-center Observational Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Severe COVID-19-associated pneumonia with or without hemoperfusion therapy
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Enrollment
- 15
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age \>18 years, 2\. Severe COVID\-19\-associated pneumonia with or without hemoperfusion therapy, 3\. Admitted in Chiang Mai University Hospital, Chiang Mai, Thailand
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Hemoperfusion in Covid 19IRCT20210718051922N1Shahre-kord University of Medical Sciences60
Recruiting
Not Applicable
Hemoperfusion effect in treatment of patients with COVID-19IRCT20110425006280N12Vice President of Research Guilan university of medical sciences20
Recruiting
Phase 2
The role of hemoperfusion in COVID-19COVID-19.COVID-19U07.1IRCT20200608047686N2Shahid Beheshti University of Medical Sciences40
Completed
Not Applicable
Clinical research for hemoperfusion therapy with an immobilized polymyxin B (PMX) fiber column in patients with severe influenza pneumonia in Vietnam and Japasevere influenza pneumoniaJPRN-UMIN000003669Disease Control and Prevention Center10
Completed
Phase 2
Hemoperfusion in patients with COVID-19IRCT20150704023055N2Babol University of Medical Sciences10